BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Norman GL, Gatselis NK, Shums Z, Liaskos C, Bogdanos DP, Koukoulis GK, Dalekos GN. Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma. World J Hepatol 2015; 7(14): 1875-1883 [PMID: 26207169 DOI: 10.4254/wjh.v7.i14.1875]
URL: https://www.wjgnet.com/1007-9327/full/v7/i14/1875.htm
Number Citing Articles
1
P. Lorenzo, A. Aspberg, T. Saxne, P. Önnerfjord. Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assaysOsteoarthritis and Cartilage 2017; 25(9): 1436 doi: 10.1016/j.joca.2017.04.004
2
Kathrin Maly, Inna Schaible, Jana Riegger, Rolf Brenner, Andrea Meurer, Frank Zaucke. The Expression of Thrombospondin-4 Correlates with Disease Severity in Osteoarthritic Knee CartilageInternational Journal of Molecular Sciences 2019; 20(2): 447 doi: 10.3390/ijms20020447
3
Rui Huang, Juan Xia, Xiaomin Yan, Yong Liu, Chao Wu. Serum cartilage oligomeric matrix protein levels as a novel non-invasive biomarker for liver fibrosis in patients with chronic viral hepatitis? It is too earlyEuropean Journal of Internal Medicine 2017; 42: e24 doi: 10.1016/j.ejim.2017.04.009
4
Andrzej Dłubak, Jakub Karwacki, Katarzyna Logoń, Paulina Tomecka, Kinga Brawańska, Wojciech Krajewski, Tomasz Szydełko, Bartosz Małkiewicz. Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future PerspectivesCurrent Oncology Reports 2023; 25(11): 1327 doi: 10.1007/s11912-023-01460-y
5
Fernando Magdaleno, Elena Arriazu, Marina Ruiz de Galarreta, Yu Chen, Xiaodong Ge, Laura Conde de la Rosa, Natalia Nieto. Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosisJournal of Hepatology 2016; 65(5): 963 doi: 10.1016/j.jhep.2016.06.003
6
Ryan W. Stidham, Jing Wu, Jiaqi Shi, David M. Lubman, Peter D. R. Higgins, John Green. Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's DiseasePLOS ONE 2017; 12(1): e0170506 doi: 10.1371/journal.pone.0170506
7
Jing Wu, David M. Lubman, Subra Kugathasan, Lee A. Denson, Jeffrey S. Hyams, Marla C. Dubinsky, Anne M. Griffiths, Robert N. Baldassano, Joshua D. Noe, Shervin Rabizadeh, Ajay S. Gulati, Joel R. Rosh, Wallace V. Crandall, Peter D.R. Higgins, Ryan W. Stidham. Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's DiseaseAmerican Journal of Gastroenterology 2019; 114(5): 777 doi: 10.14309/ajg.0000000000000237
8
Sebastian D. Graf, Corinna U. Keber, Akira Hattesohl, Julia Teply‐Szymanski, Sophia Hattesohl, Marc Guder, Norman Gercke, Pietro Di Fazio, Emily P. Slater, Moritz Jesinghaus, Carsten Denkert, Detlef K. Bartsch, Bettina Lehman. Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha‐smooth muscle actin‐positive fibrosis and COMP‐expressing stromal cellsJournal of Neuroendocrinology 2024; 36(2) doi: 10.1111/jne.13364
9
Khaa Hoo Ong, Yao-Yu Hsieh, Hong-Yue Lai, Ding-Ping Sun, Tzu-Ju Chen, Steven Kuan-Hua Huang, Yu-Feng Tian, Chia-Ling Chou, Yow-Ling Shiue, Hung-Chang Wu, Ti-Chun Chan, Hsin-Hwa Tsai, Chien-Feng Li, Po-An Su, Yu-Hsuan Kuo. Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinomaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-43006-z
10
Xiang Yu, Hao Zhang, Jinze Li, Lu Gu, Lei Cao, Jun Gong, Ping Xie, Jian Xu. Construction of a prognostic prediction model in liver cancer based on genes involved in integrin cell surface interactions pathway by multi-omics screeningFrontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1237445
11
Kalliopi Zachou, Stella Gabeta, Nikolaos K. Gatselis, Gary L. Norman, George N. Dalekos. Cartilage oligomeric matrix protein on the spot for liver fibrosis evaluation: Too early or too late?European Journal of Internal Medicine 2017; 43: e48 doi: 10.1016/j.ejim.2017.05.003
12
Bingjie Guo, Yajing Wang, Wenyu Liu, Sailong Zhang. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer typesClinical and Translational Oncology 2022; 25(2): 535 doi: 10.1007/s12094-022-02968-8
13
Nikolaos K. Gatselis, Kalliopi Zachou, George Giannoulis, Stella Gabeta, Gary L. Norman, George N. Dalekos. Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?Cancers 2021; 13(14): 3510 doi: 10.3390/cancers13143510
14
Jufeng Xia, Peipei Song, Zhipeng Sun, Tatsuo Sawakami, Mingku Jia, Zhigang Wang. Advances of diagnostic and mechanistic studies of γ-glutamyl transpeptidase in hepatocellular carcinomaDrug Discoveries & Therapeutics 2016; 10(4): 181 doi: 10.5582/ddt.2016.01052
15
Stijn Van Hees, Peter Michielsen, Thomas Vanwolleghem. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(37): 8271-8282 doi: 10.3748/wjg.v22.i37.8271
16
Kalliopi Zachou, Stella Gabeta, Zakera Shums, Nikolaos K. Gatselis, George K. Koukoulis, Gary L. Norman, George N. Dalekos. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitisEuropean Journal of Internal Medicine 2017; 38: 83 doi: 10.1016/j.ejim.2017.01.007
17
Nikolaos K Gatselis, Tamás Tornai, Zakera Shums, Kalliopi Zachou, Asterios Saitis, Stella Gabeta, Roger Albesa, Gary L Norman, Mária Papp, George N Dalekos. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patientsWorld Journal of Gastroenterology 2020; 26(34): 5130-5145 doi: 10.3748/wjg.v26.i34.5130
18
Qing Li, Cong Wang, Yufeng Wang, Liankang Sun, Zhikui Liu, Liang Wang, Tao Song, Yingmin Yao, Qingguang Liu, Kangsheng Tu. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathwaysJournal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0908-y
19
Jiarui Cui, Jiaming Zhang. Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic OpportunitiesInternational Journal of Molecular Sciences 2022; 23(16): 9253 doi: 10.3390/ijms23169253
20
Kristofer Andréasson, Göran Jönsson, Roger Hesselstrand, Hans Norrgren. Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradicationWorld Journal of Hepatology 2019; 11(3): 330-334 doi: 10.4254/wjh.v11.i3.330
21
Ying-Qiu Huang. Recent advances in the diagnosis and treatment of primary biliary cholangitisWorld Journal of Hepatology 2016; 8(33): 1419-1441 doi: 10.4254/wjh.v8.i33.1419
22
Yu-Hsuan Kuo, Hong-Yue Lai, Ti-Chun Chan, Chung-Hsi Hsing, Steven K Huang, Kun-Lin Hsieh, Tzu-Ju Chen, Wan-Shan Li, Jhih-Cheng Lu, Chien-Feng Li. Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial CarcinomaOncoTargets and Therapy 2022; : 727 doi: 10.2147/OTT.S370028